NIH PAR · NICHD · R01
PAR-25-185: Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including human congenital anomalies (HCAs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs). Large quantities of genomic data collected from pediatric congenital anomalies cohorts are available to the research community through several databases such as the Database of Genotypes and Phenotypes (dbGaP), the Gabriella Miller Kids First Data Resource Portal, the European Genome-Phenome Archive and Clinical Genome Resource (ClinGen). The purpose of this initiative is to…
- NOFO number
- PAR-25-185
- Type
- PAR
- Activity code
- R01
- Primary institute
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Clinical trials
- Not Allowed
- Posted
- Oct 30, 2024
- Opens
- Jan 5, 2025
- Expires
- Jan 8, 2028
PAR-25-185 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | Not Applicable | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | Not Applicable | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | Not Applicable | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | Not Applicable | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 05, 2027 | March 05, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 05, 2027 | July 05, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 05, 2027 | November 05, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-185
NIH RePORTER lists 4 projects funded under PAR-25-185 in FY2022–FY2026, with $2.2M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
4
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$2.2M
Award dollars under PAR-25-185, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 4 | 4 | $2.2M |
Institutions with the most funding
- Medical College of Wisconsin$715K · 1 project
- University of Connecticut Sch of Med/Dnt$578K · 1 project
- Yale University$500K · 1 project
- University of Michigan at Ann Arbor$443K · 1 project
Funding institutes
- NICHD$1.8M · 3
- NIDCR$443K · 1
Activity codes funded
- R013 records
- R561 record
Most recent new awards
- The functional screening of congenital hydrocephalus and heart disease genes in Xenopus (opens NIH RePORTER)
Yale University · 1R56HD120596-01A1 · NICHD · Notice Sep 17, 2026
$500KR56
- lncRNA disruption: A previously unexplored cause of congenital anomalies (opens NIH RePORTER)
University of Connecticut Sch of Med/Dnt · 1R01HD121516-01 · NICHD · Notice Sep 17, 2026
$578KR01
- Discovery, Validation, and Mitigation of Genetic Mutations Underlying Hereditary Enamel Defects (opens NIH RePORTER)
University of Michigan at Ann Arbor · 1R01DE035445-01A1 · NIDCR · Notice Aug 3, 2026
$443KR01
- Validating Causality of Disputed Mitochondrial Variants in Inborn Errors of Metabolism (opens NIH RePORTER)
Medical College of Wisconsin · 1R01HD121570-01 · NICHD · Notice Jun 19, 2026
$715KR01
What its predecessor PAR-21-229 funded
PAR-25-185 reissues PAR-21-229. Its funding history is the best guide to who wins under this program: 10 projects and $20.9M in FY2022–FY2026.
Projects funded
10
Distinct projects, FY2022–FY2026
New awards
10
Type 1 (new project) award records
NIH funding
$20.9M
Award dollars under PAR-21-229, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 1 | 1 | $725K |
| FY2023 | 6 | 6 | $4.2M |
| FY2024 | 7 | 1 | $4.7M |
| FY2025 | 9 | 2 | $5.7M |
| FY2026 | 9 | 0 | $5.6M |
Institutions with the most funding
- University of Pittsburgh at Pittsburgh$4.1M · 2 projects
- University of Calif-Lawrenc Berkeley Lab$3.3M · 1 project
- University of Maryland Baltimore$2.6M · 1 project
- Children's Hosp of Philadelphia$2.6M · 1 project
- Children's Mercy Hosp (Kansas City, Mo)$2.6M · 1 project
- Washington University$2.5M · 1 project
- University of Alabama at Birmingham$1.8M · 1 project
- University of Kentucky$828K · 1 project
Funding institutes
- NICHD$13.6M · 21
- NIDCR$7.4M · 11
Activity codes funded
- R0131 records
- R561 record
Most recent new awards
- Leveraging whole genome sequencing and functional genomic characterization to improve NSCLP gene discovery (opens NIH RePORTER)
University of Pittsburgh at Pittsburgh · 1R01DE033908-01A1 · NIDCR · Notice Apr 16, 2025
$645KR01
- Functional Characterization of Genetic Variants in Rare Disease Associated with Shoc2 scaffold (opens NIH RePORTER)
University of Kentucky · 1R01HD118715-01 · NICHD · Notice Apr 10, 2025
$419KR01
- Mechanisms of ciliopathy associated structural birth defects (opens NIH RePORTER)
University of Alabama at Birmingham · 1R01HD111399-01A1 · NICHD · Notice Sep 5, 2024
$603KR01
- Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects (opens NIH RePORTER)
University of Calif-Lawrenc Berkeley Lab · 1R01HD114353-01 · NICHD · Notice Sep 21, 2023
$817KR01
- Screen and functional validation of Pediatric Cardiomyopathy genetic variants in Drosophila (opens NIH RePORTER)
University of Maryland Baltimore · 1R01HD111480-01 · NICHD · Notice Apr 4, 2023
$650KR01
- Functional analysis of ESRP1/2 and CTNND1 gene variants in orofacial cleft (opens NIH RePORTER)
Children's Hosp of Philadelphia · 1R01DE032332-01 · NIDCR · Notice Feb 8, 2023
$676KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
3 NIH institutes and offices take applications under PAR-25-185. Contact the program officer at the institute that fits your research before applying.
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCR · National Institute of Dental and Craniofacial Research
- ORIP
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to 499,999 direct costs per year and need to reflect the actual needs of the proposed projects.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-21-229.
Other open NOFOs for R01
- PAR-25-362Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)NICHD · next due Feb 5, 2027
- PAR-25-265Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)NICHD · next due Feb 5, 2027
- PAR-25-112Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)NICHD · next due Feb 5, 2027
- PAR-25-227Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)NICHD · next due Feb 5, 2027
- PAR-25-371Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)NHGRI · next due Oct 20, 2026
- PAR-25-379Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)NIDA · next due Oct 21, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.